(NASDAQ: CODX) Co Diagnostics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 24.21%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 35.93%.
Co Diagnostics's earnings in 2026 is -$32,181,403.On average, 4 Wall Street analysts forecast CODX's earnings for 2026 to be -$25,154,729, with the lowest CODX earnings forecast at -$26,853,632, and the highest CODX earnings forecast at -$23,017,399. On average, 3 Wall Street analysts forecast CODX's earnings for 2027 to be -$24,844,177, with the lowest CODX earnings forecast at -$23,869,895, and the highest CODX earnings forecast at -$25,574,888.
In 2028, CODX is forecast to generate $29,194,827 in earnings, with the lowest earnings forecast at $28,049,932 and the highest earnings forecast at $30,053,499.